Bioscience
Primavera Essentials introduces Neuro-Eze
FORT COLLINS -- Primavera Essentials, Inc. announced the launch of Neuro-Eze, a highly specialized topical gel that may help lessen the pain and numbness that neuropathy patients experience in... Read More
Friday April 30, 2021 0 comments
Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19
WESTMINSTER -- Reven Holdings, Inc. today announced the first patient has been dosed in the Phase I/II trial of RJX in high-risk COVID-19 patients ( ClinicalTrials.gov Identifier: NCT04708340; ... Read More
Thursday April 29, 2021 0 comments
KromaTiD receives $2M of growth investment from BroadOak Capital Partners
LONGMONT -- KromaTiD announced BroadOak Capital Partners made a $2M investment in the company. KromaTiD said its sales and operations are rapidly accelerating, driven by growing market... Read More
Thursday April 29, 2021 0 comments
Ampio: Ampion reduces all-cause mortality in COVID-19 respiratory distress by nearly 80%
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in patients as a... Read More
Wednesday April 28, 2021 0 comments
CereHealth granted patent for medical imaging quantification
DENVER -- CereHealth Corporation announced it has been granted a third patent on its novel systems and methodologies used in its FDA-cleared CereMetrix medical imaging and data analytics software. ... Read More
Friday April 23, 2021 0 comments
Research shows Ampion mimics anti-inflammatory effects of steroids but without adverse effects
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced findings of pre-clinical research demonstrating Ampio's lead drug candidate, Ampion, provides some of the same anti-inflammatory... Read More
Tuesday April 20, 2021 0 comments
VieCure announces $25M Series A investment led by Northpond Ventures to improve oncology care, scale A.I. and patient-focused technologies
DENVER -- VieCure , Inc . today announced the closing of a $25 million Series A growth equity investment, led by Northpond Ventures . An undisclosed investor is also contributing to the... Read More
Tuesday April 20, 2021 0 comments
TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors
DENVER -- The University of Texas MD Anderson Cancer Center and Denver-based TriSalus Life Sciences announced a strategic research collaboration to evaluate the treatment of tumors of the... Read More
Thursday April 15, 2021 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
